C160H169BrF12N42O6 — CID 158605096
1-[3-bromo-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-3-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)urea;1-(4-isoquinolin-7-yl-5-methyl-1H-imidazol-2-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(2-methylpiperidin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]urea;1-[1-methyl-5-(2-methylquinazolin-6-yl)-1,2,4-triazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea (PubChem CID 158605096) has the molecular formula C160H169BrF12N42O6 and a molecular weight of 3084.28 g/mol. Its IUPAC name is 1-[3-bromo-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-3-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)urea;1-(4-isoquinolin-7-yl-5-methyl-1H-imidazol-2-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(2-methylpiperidin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]urea;1-[1-methyl-5-(2-methylquinazolin-6-yl)-1,2,4-triazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea.
| Compound Name | 1-[3-bromo-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-3-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)urea;1-(4-isoquinolin-7-yl-5-methyl-1H-imidazol-2-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(2-methylpiperidin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]urea;1-[1-methyl-5-(2-methylquinazolin-6-yl)-1,2,4-triazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea |
|---|---|
| PubChem CID | 158605096 |
| Molecular Formula | C160H169BrF12N42O6 |
| Molecular Weight | 3084.28 g/mol |
| Exact Mass | 3081.32 |
| IUPAC Name | 1-[3-bromo-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-3-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)urea;1-(4-isoquinolin-7-yl-5-methyl-1H-imidazol-2-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-[(2-methylpiperidin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea;1-(5-isoquinolin-7-yl-1-methylpyrazol-3-yl)-3-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]urea;1-[1-methyl-5-(2-methylquinazolin-6-yl)-1,2,4-triazol-3-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]urea |
| SMILES | CC1CCCCN1Cc1ccc(NC(=O)Nc2cc(-c3ccc4ccncc4c3)n(C)n2)cc1C(F)(F)F.CN1CCN(Cc2ccc(NC(=O)Nc3cc(-c4ccc5ccncc5c4)n(C)n3)cc2)CC1.CN1CCN(Cc2ccc(NC(=O)Nc3cc(-c4ccc5ccncc5c4)n(C)n3)cc2Br)CC1.Cc1[nH]c(NC(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)nc1-c1ccc2ccncc2c1.Cc1ncc2cc(-c3nc(NC(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)nn3C)ccc2n1.Cn1nc(NC(=O)Nc2ccc(CN3CCCCC3)c(C(F)(F)F)c2)cc1-c1ccc2ccncc2c1 |
| InChI | InChI=1S/C28H29F3N6O.C27H28F3N7O.C27H27F3N6O.C26H28BrN7O.C26H28F3N9O.C26H29N7O/c1-18-5-3-4-12-37(18)17-21-8-9-23(14-24(21)28(29,30)31)33-27(38)34-26-15-25(36(2)35-26)20-7-6-19-10-11-32-16-22(19)13-20;1-17-24(19-4-3-18-7-8-31-15-21(18)13-19)34-25(32-17)35-26(38)33-22-6-5-20(23(14-22)27(28,29)30)16-37-11-9-36(2)10-12-37;1-35-24(19-6-5-18-9-10-31-16-21(18)13-19)15-25(34-35)33-26(37)32-22-8-7-20(23(14-22)27(28,29)30)17-36-11-3-2-4-12-36;1-32-9-11-34(12-10-32)17-20-5-6-22(14-23(20)27)29-26(35)30-25-15-24(33(2)31-25)19-4-3-18-7-8-28-16-21(18)13-19;1-16-30-14-19-12-17(5-7-22(19)31-16)23-33-24(35-37(23)3)34-25(39)32-20-6-4-18(21(13-20)26(27,28)29)15-38-10-8-36(2)9-11-38;1-31-11-13-33(14-12-31)18-19-3-7-23(8-4-19)28-26(34)29-25-16-24(32(2)30-25)21-6-5-20-9-10-27-17-22(20)15-21/h6-11,13-16,18H,3-5,12,17H2,1-2H3,(H2,33,34,35,38);3-8,13-15H,9-12,16H2,1-2H3,(H3,32,33,34,35,38);5-10,13-16H,2-4,11-12,17H2,1H3,(H2,32,33,34,37);3-8,13-16H,9-12,17H2,1-2H3,(H2,29,30,31,35);4-7,12-14H,8-11,15H2,1-3H3,(H2,32,34,35,39);3-10,15-17H,11-14,18H2,1-2H3,(H2,28,29,30,34) |
| InChIKey | HWCSWNKUTKRJAF-UHFFFAOYSA-N |
| XLogP | 31.26 |
| TPSA | 500.08 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 221 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3084.28 |
| LogP ≤ 5 | 31.26 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 35 |